• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » American Cancer Society enrolls thousands in prevention study

American Cancer Society enrolls thousands in prevention study

August 24, 2011
CenterWatch Staff

For the past two years, the American Cancer Society has been enrolling people across the country in its latest research project, cancer prevention study-3, according to a report in the Indianapolis Star. In the first week of October, eight of Indianapolis’ major employers will contribute, signing up people at their work sites.

So far, about 1,200 in the Indianapolis area have enrolled in the study, and the organization is hoping to bring in an additional 1,000 new participants during the October effort, communications manager Brandi Davis-Handy said. The national goal is to recruit 300,000 people by the end of 2013.

The work sites, which include Eli Lilly, Roche Diagnostics, hospitals and churches, will invite the public to sign up as well.

Indianapolis is the second city to hold a mass enrollment. Atlanta, home to the cancer society, recently held a similar enrollment.

Studies such as this play an integral role in the battle against cancer, said Linda Wilgus, executive director of Northwest Radiology Network and volunteer chair for the local project. "Once we find why someone gets cancer, we can then figure out how to prevent it," Wilgus said.

Enrollment requires participants to complete a brief questionnaire; get height, weight and waist measurements; and provide a blood sample. Over the next 20 years, participants will be asked to fill out follow-up questionnaires.

Once all 300,000 participants are enrolled -- the study already is a third of the way there -- cancer prevention study-3 will be the largest study ever to collect blood samples from all participants, said Alpa Patel, strategic director of the study.

The blood samples will allow researchers to look at the role genetics can play in cancer. The questionnaires will provide clues to the role of lifestyle choices in cancer, Patel said. Waist measurements will help determine how bad visceral fat -- the extra pounds carried around essential organs -- is for a person, Patel said.

Each year, about 7,500 people in Central Indiana are diagnosed with cancer, or about 20 a day, said Linda House, executive director of St. Vincent Care, one of the participating employers.

For three days during the October sign-up period, St. Vincent will allow its employees to sign up on work time and invite all hospital visitors to participate, House said. This is the first time that the hospital has taken part in such an initiative.

Upcoming Events

  • 17May

    Three Data Trends to Consider Now When Developing Your Decentralized Clinical Trial Strategy

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing